A practical, dynamic resource for practicing neurologists, clinicians and trainees, Bradley and Daroff's Neurology in Clinical Practice, Eighth Edition, offers a straightforward style, evidence-based information, and robust interactive content supplemented by treatment algorithms and images to keep you up to date with all that’s current in this fast-changing field. This two-volume set is ideal for daily reference, featuring a unique organization by presenting symptom/sign and by specific disease entities―allowing you to access content in ways that mirror how you practice. More than 150 expert contributors, led by Drs. Joseph Jankovic, John C. Mazziotta, Scott L. Pomeroy, and Nancy J. Newman, provide up-to-date guidance that equips you to effectively diagnose and manage the full range of neurological disorders.- Covers all aspects of today’s neurology in an easy-to-read, clinically relevant manner.
- Allows for easy searches through an intuitive organization by both symptom and grouping of diseases.
- Features new and expanded content on movement disorders, genetic and immunologic disorders, tropical neurology, neuro-ophthalmology and neuro-otology, palliative care, pediatric neurology, and new and emerging therapies.
- Offers even more detailed videos that depict how neurological disorders manifest, including EEG and seizures, deep brain stimulation for PD and tremor, sleep disorders, movement disorders, ocular oscillations, EMG evaluation, cranial neuropathies, and disorders of upper and lower motor neurons, as well as other neurologic signs.
- Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.
Author(s): Joseph Jankovic MD, John C. Mazziotta MD PhD, Scott L Pomeroy MD PhD, Nancy J. Newman MD
Series: Bradley's Neurology in Clinical Practice
Edition: 8
Publisher: Elsevier
Year: 2021
Language: English
Pages: 2400
01
02
03
Bradley and Daroff's Neurology in Clinical Practice (8th Edition)-2022.pdf (p.1-2875)
i - 0
ii - 1
ii - 2
ii - Dedication
Dedication
iii Volume I - Front Matter of Volume I
BRADLEY and DAROFF’S NEUROLOGY in Clinical Practice
iii Volume II - Front Matter of Volume II
BRADLEY and DAROFF’S NEUROLOGY in Clinical Practice
iv - Copyright
copyright
v - content
id=b1slEAAAQBAJ&pg=RA1-PR5&img=1&zoom=3&hl=en&sig=ACfU3U1TOIwnV
id=b1slEAAAQBAJ&pg=RA1-PR6&img=1&zoom=3&hl=en&sig=ACfU3U2Ci7wv1
id=b1slEAAAQBAJ&pg=RA1-PR7&img=1&zoom=3&hl=en&sig=ACfU3U2NgFZJX
viii - Preface
PREFACE
x - List of Contributors
LIST OF CONTRIBUTORS
xx -
1 - 1 - Diagnosis of Neurological Disease
1 - Diagnosis of Neurological Disease
8 - 2 – Episodic Impairment of Consciousness
2 - Episodic Impairment of Consciousness
SYNCOPE
History and Physical Examination
Causes of Syncope
Investigations of Patients with Syncope
SEIZURES
Pathophysiology
History and Physical Examination
SEIZURE CLASSIFICATION
Absence Seizures
Tonic-Clonic Seizures
Complex Partial Seizures
Investigations of Seizures
Psychogenic Nonepileptic Spells
MISCELLANEOUS CAUSES OF ALTERED CONSCIOUSNESS
REFERENCES
17 - 3 - Falls and Drop Attacks
3 - Falls and Drop Attacks
FALLS AND DROP ATTACKS—INTRODUCTION
23 - 4 - Delirium
4 - Delirium
CLINICAL CHARACTERISTICS
34 - 5 - Stupor and Coma
52 - 6 - Prolonged Comatose States and Brain Death
58 - 7 - Intellectual and Memory Impairments
67 - 8 - Global Developmental Delay and Regression
8 - Global Developmental Delay and Regression
TYPICAL AND ATYPICAL DEVELOPMENT
75 - 9 - Behavior and Personality Disturbances
9 - Behavior and Personality Disturbances
97 - 10 - Depression and Psychosis in Neurological Practice
10 - Depression and Psychosis in Neurological Practice
PRINCIPLES OF DIFFERENTIAL DIAGNOSIS
120 - 11 - Limb Apraxias and Related Disorders
127 - 12 - Agnosias
12 - Agnosias
VISUAL AGNOSIAS
133 - 13 - Aphasia and Aphasic Syndromes
13 - Aphasia and Aphasic Syndromes
149 - 14 - Dysarthria and Apraxia of Speech
14 - Dysarthria and Apraxia of Speech
MOTOR SPEECH DISORDERS
152 - 15 - Neurogenic Dysphagia
164 - 16 - Neuro-Ophthalmology_ Afferent Visual System
191 - 17 - Pupillary and Eyelid Abnormalities
17 - Pupillary and Eyelid Abnormalities
PUPILLARY ABNORMALITIES
201 - 18 - Neuro-ophthalmology_ Ocular Motor System
18 - Neuro-ophthalmology: Ocular Motor System
GENERAL PRINCIPLES OF OCULAR MOTOR CONTROL
EYE MOVEMENT ANATOMY
241 - 19 - Disturbances of Smell and Taste
19 - Disturbances of Smell and Taste
ANATOMY AND PHYSIOLOGY
248 - 20 - Cranial and Facial Pain
255 - 21 - Brainstem Syndromes
21 - Brainstem Syndromes
OCULAR MOTOR SYNDROMES
267 - 22 - Neuro-Otology_ Diagnosis and Management of Neuro-Otological Disorders
22 - Neuro-Otology: Diagnosis and Management of Neuro-Otological Disorders
HISTORICAL BACKGROUND
288 - 23 - Cerebellar Ataxia
23 - Cerebellar Ataxia
310 - 24 - Diagnosis and Assessment of Parkinson Disease and Other Movement Disorders
24 - Diagnosis and Assessment of Parkinson Disease and Other Movement Disorders
334 - 25 - Gait Disorders
25 - Gait Disorders
345 - 26 – Hemiplegia and Monoplegia
26 - Hemiplegia and Monoplegia
ANATOMY AND PHYSIOLOGY
356 - 27 - Paraplegia and Spinal Cord Syndromes
27 - Paraplegia and Spinal Cord Syndromes
362 - 28 - Proximal, Distal, and Generalized Weakness
28 - Proximal, Distal, and Generalized Weakness
379 - 29 - Muscle Pain and Cramps
29 - Muscle Pain and Cramps
388 - 30 - Hypotonic (Floppy) Infant
30 - Hypotonic (Floppy) Infant
397 - 31 - Sensory Abnormalities of the Limbs, Trunk, and Face
31 - Sensory Abnormalities of the Limbs, Trunk, and Face
ANATOMY AND PHYSIOLOGY
407 - 32 - Arm and Neck Pain
32 - Arm and Neck Pain
CLINICAL ASSESSMENT
417 - 33 - Lower Back and Lower Limb Pain
33 - Lower Back and Lower Limb Pain
ANATOMY AND PHYSIOLOGY
APPROACH TO DIAGNOSIS OF LOW BACK AND LEG PAIN
427 - Investigations in the Diagnosis and Management of Neurological Disease
34 - Investigations in the Diagnosis and Management of Neurological Disease
DIAGNOSTIC YIELD OF ANCILLARY TESTS
INTERPRETATION OF RESULTS OF INVESTIGATIONS
RELIABILITY OF INVESTIGATIONS
DECISION ANALYSIS
RESEARCH INVESTIGATIONS AND TEACHING HOSPITALS
PATIENT CONFIDENTIALITY
430 - 35 - Electroencephalography and Evoked Potentials
35 - Electroencephalography and Evoked Potentials
447 - 36 - Clinical Electromyography
36 - Clinical Electromyography
NERVE CONDUCTION STUDIES
472 - 37 - Extracranial Neuromodulation
37 - Extracranial Neuromodulation
483 - 38 - Intracranial Neuromodulation
38 - Intracranial Neuromodulation
492 - 39 - Intraoperative Monitoring
39 - Intraoperative Monitoring
496 - 40 - Structural Imaging Using Magnetic Resonance Imaging and Computed Tomography
40 - Structural Imaging Using Magnetic Resonance Imaging and Computed Tomography
547 - 41 - Vascular Imaging_ Computed Tomographic Angiography, Magnetic Resonance Angiography, and Ultrasound
41 - Vascular Imaging: Computed Tomographic Angiography, Magnetic Resonance Angiography, and Ultrasound
COMPUTED TOMOGRAPHIC ANGIOGRAPHY
576 - 42 - Functional and Molecular Neuroimaging
42 - Functional and Molecular Neuroimaging
601 - 43 - Ocular Functional and Structural Investigations
43 - Ocular Functional and Structural Investigations
614 - 44 - Neuropsychology
44 - Neuropsychology
633 - 45 - Neurourology
45 - Neurourology
652 - 46 - Sexual Dysfunction in Neurological Disorders
46 - Sexual Dysfunction in Neurological Disorders
666 - 47 - Neuroepidemiology
47 - Neuroepidemiology
681 - 48 - Clinical Neurogenetics
48 - Clinical Neurogenetics
GENETICS IN CLINICAL NEUROLOGY
709 - 49 - Neuroimmunology
49 - Neuroimmunology
IMMUNE SYSTEM
730 - 50 - Neuroendocrinology
50 - Neuroendocrinology
748 - 51 - Management of Neurological Disease
51 - Management of Neurological Disease
753 - 52 - Pain Management
52 - Pain Management
DEFINITION AND CHALLENGE
776 - 53 - Neurointensive Care
53 - Neurointensive Care
793 - 54 - Principles of Neuroendovascular Therapy
54 - Principles of Neuroendovascular Therapy
819 - 55 - Neurological Rehabilitation
B - Neurological Complications of Systemic Disease
55 - Neurological Rehabilitation
850 - 56 - Transition to Adult Care for Youth with Chronic Neurological Disorders
856 - 57 - Palliative and End-of-Life Care in Neurological Disease
57 - Palliative and End-of-Life Care in Neurological Disease
862 - 58 - Neurological Complications of Systemic Disease_ Adults_
58 - Neurological Complications of Systemic Disease: Adults*
882 - 59 - Neurological Complications of Systemic Disease_ Children
59 - Neurological Complications of Systemic Disease: Children
897 - 60 - Basic Neuroscience of Neurotrauma
60 - Basic Neuroscience of Neurotrauma
907 - 61 - Concussion in Sports and Performance
61 - Concussion in Sports and Performance
914 - 62 – Craniocerebral Trauma
62 - Craniocerebral Trauma
929 - 63 - Spinal Cord Trauma
63 - Spinal Cord Trauma
EPIDEMIOLOGY
950 - 64 - Trauma of the Nervous System_ Peripheral Nerve Trauma
64 - Trauma of the Nervous System: Peripheral Nerve Trauma
964 - 65 - Ischemic Cerebrovascular Disease
65 - Ischemic Cerebrovascular Disease
1014 - 66 - Intracerebral Hemorrhage
66 - Intracerebral Hemorrhage
1031 - 67 - Intracranial Aneurysms and Subarachnoid Hemorrhage
67 - Intracranial Aneurysms and Subarachnoid Hemorrhage
EPIDEMIOLOGY
1044 - 68 - Stroke in Children
68 - Stroke in Children
1058 - 69 - Spinal Cord Vascular Disease
69 - Spinal Cord Vascular Disease
1066 - 70 - Central Nervous System Vasculitis
70 - Central Nervous System Vasculitis
1068 - 71 - Epidemiology of Brain Tumors
71 - Epidemiology of Brain Tumors
1076 - 72 - Pathology and Molecular Genetics
72 - Pathology and Molecular Genetics
1099 - 73 - Clinical Features of Brain Tumors and Complications of Their Treatment
73 - Clinical Features of Brain Tumors and Complications of Their Treatment
1105 - 74 - Primary Nervous System Tumors in Adults
74 - Primary Nervous System Tumors in Adults
GENERAL ASPECTS
1122 - 75 - Primary Nervous System Tumors in Infants and Children
75 - Primary Nervous System Tumors in Infants and Children
1145 - 76 - Nervous System Metastases
76 - Nervous System Metastases
BRAIN METASTASES
1165 - 77 - Neurological Manifestations of Human Immunodeficiency Virus Infection in Adults
77 - Neurological Manifestations of Human Immunodeficiency Virus Infection in Adults
EPIDEMIOLOGY AND CURRENT TRENDS
1184 - 78 - Viral Encephalitis and Meningitis
78 - Viral Encephalitis and Meningitis
1214 - 79 - Bacterial, Fungal, and Parasitic Diseases of the Nervous System
79 - Bacterial, Fungal, and Parasitic Diseases of the Nervous System
1226 - 80 - Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System
80 - Multiple Sclerosis and Other Inflammatory Demyelinating Diseases of the Central Nervous System
1255 - 81 - Paraneoplastic Disorders of the Nervous System
81 - Paraneoplastic Disorders of the Nervous System
1263 - 82 - Autoimmune Encephalitis with Antibodies to Cell Surface Antigens
82 - Autoimmune Encephalitis with Antibodies to Cell Surface Antigens
1269 - 83 - Anoxic-Ischemic Encephalopathy
83 - Anoxic-Ischemic Encephalopathy
PATHOPHYSIOLOGICAL CONCEPTS
1276 - 84 - Toxic and Metabolic Encephalopathies
84 - Toxic and Metabolic Encephalopathies
1291 - 85 - Deficiency Diseases of the Nervous System
85 - Deficiency Diseases of the Nervous System
COBALAMIN (VITAMIN B12)
1302 - 86 - Effects of Toxins and Physical Agents on the Nervous System
86 - Effects of Toxins and Physical Agents on the Nervous System
1319 - 87 - Effects of Drug Abuse on the Nervous System
87 - Effects of Drug Abuse on the Nervous System
DRUGS OF DEPENDENCE
1327 - 88 - Brain Edema and Disorders of Cerebrospinal Fluid Circulation
88 - Brain Edema and Disorders of Cerebrospinal Fluid Circulation
1345 - 89 - Developmental Disorders of the Nervous System
89 - Developmental Disorders of the Nervous System
1366 - 90 - Autism and Other Neurodevelopmental Disabilities
90 - Autism and Other Neurodevelopmental Disabilities
1386 - 91 - Inborn Errors of Metabolism and the Nervous System
91 - Inborn Errors of Metabolism and the Nervous System
1407 - 92 - Neurodegenerative Disease Processes
92 - Neurodegenerative Disease Processes
WHERE DO NEURODEGENERATIVE DISORDERS BEGIN?
1415 - 93 - Mitochondrial Disorders
93 - Mitochondrial Disorders
1430 - 94 - Prion Diseases
94 - Prion Diseases
1452 - 95 - Alzheimer Disease and Other Dementias
95 - Alzheimer Disease and Other Dementias
1498 - 96 - Parkinson Disease and Other Movement Disorders
96 - Parkinson Disease and Other Movement Disorders
1535 - 97 - Disorders of Upper and Lower Motor Neurons
97 - Disorders of Upper and Lower Motor Neurons
1568 - 98 - Channelopathies_ Episodic and Electrical Disorders of the Nervous System
98 - Channelopathies: Episodic and Electrical Disorders of the Nervous System
1589 - 99 – Neurocutaneous Syndromes
99 - Neurocutaneous Syndromes
1614 - 100 – Epilepsies
100 - Epilepsies
1664 - 101 - Sleep and Its Disorders
101- Sleep and Its Disorders
1745 - 102 - Headache and Other Craniofacial Pain
102 - Headache and Other Craniofacial Pain
PAIN TRANSMISSION AND MODULATION AS RELATED TO HEADACHE
1783 - 103 - Cranial Neuropathies
103 - Cranial Neuropathies
OLFACTORY NERVE (CRANIAL NERVE I)
1798 - 104 - Disorders of Bones, Joints, Ligaments, and Meninges
104 - Disorders of Bones, Joints, Ligaments, and Meninges
1829 - 105 - Disorders of Nerve Roots and Plexuses
105 - Disorders of Nerve Roots and Plexuses
DISORDERS OF NERVE ROOTS
1853 - 106 - Disorders of Peripheral Nerves
106 - Disorders of Peripheral Nerves
CLINICAL APPROACH TO DISORDERS OF PERIPHERAL NERVES
1930 - 107 - Disorders of the Autonomic Nervous System
107 - Disorders of the Autonomic Nervous System
1958 - 108 - Disorders of Neuromuscular Transmission
108 - Disorders of Neuromuscular Transmission
1978 - 109 - Disorders of Skeletal Muscle
109 - Disorders of Skeletal Muscle
2022 - 110 – Neurological Problems in the Newborn
110 - Neurological Problems in the Newborn
2040 - 111 - Cerebral Palsy
111 - Cerebral Palsy
2049 - 112 - Neurological Problems of Pregnancy
112 - Neurological Problems of Pregnancy
NEUROLOGICAL COMPLICATIONS OF CONTRACEPTION
2076 - 113 - Functional and Dissociative Neurological Symptoms and Disorders
113 - Functional and Dissociative Neurological Symptoms and Disorders
2093 - index
Index M
id=b1slEAAAQBAJ&pg=RA2-PA101&img=1&zoom=3&hl=en&sig=ACfU3U1RYwg
id=b1slEAAAQBAJ&pg=RA2-PA102&img=1&zoom=3&hl=en&sig=ACfU3U1mpHZ
id=b1slEAAAQBAJ&pg=RA2-PA103&img=1&zoom=3&hl=en&sig=ACfU3U0w7TO
id=b1slEAAAQBAJ&pg=RA2-PA104&img=1&zoom=3&hl=en&sig=ACfU3U2vTLC
id=b1slEAAAQBAJ&pg=RA2-PA105&img=1&zoom=3&hl=en&sig=ACfU3U1XLr6
id=b1slEAAAQBAJ&pg=RA2-PA106&img=1&zoom=3&hl=en&sig=ACfU3U03niJ
id=b1slEAAAQBAJ&pg=RA2-PA107&img=1&zoom=3&hl=en&sig=ACfU3U2_b4M
id=b1slEAAAQBAJ&pg=RA2-PA108&img=1&zoom=3&hl=en&sig=ACfU3U2L1tN
id=b1slEAAAQBAJ&pg=RA2-PA109&img=1&zoom=3&hl=en&sig=ACfU3U0m-XR
id=b1slEAAAQBAJ&pg=RA2-PA110&img=1&zoom=3&hl=en&sig=ACfU3U232j8
id=b1slEAAAQBAJ&pg=RA2-PA111&img=1&zoom=3&hl=en&sig=ACfU3U1_TCg
id=b1slEAAAQBAJ&pg=RA2-PA112&img=1&zoom=3&hl=en&sig=ACfU3U3e0yB
id=b1slEAAAQBAJ&pg=RA2-PA113&img=1&zoom=3&hl=en&sig=ACfU3U3QqZc
id=b1slEAAAQBAJ&pg=RA2-PA114&img=1&zoom=3&hl=en&sig=ACfU3U059db
id=b1slEAAAQBAJ&pg=RA2-PA115&img=1&zoom=3&hl=en&sig=ACfU3U024iz
id=b1slEAAAQBAJ&pg=RA2-PA116&img=1&zoom=3&hl=en&sig=ACfU3U3_6cb
id=b1slEAAAQBAJ&pg=RA2-PA117&img=1&zoom=3&hl=en&sig=ACfU3U354qs
id=b1slEAAAQBAJ&pg=RA2-PA118&img=1&zoom=3&hl=en&sig=ACfU3U3F5da
id=b1slEAAAQBAJ&pg=RA2-PA119&img=1&zoom=3&hl=en&sig=ACfU3U1gWX1
id=b1slEAAAQBAJ&pg=RA2-PA120&img=1&zoom=3&hl=en&sig=ACfU3U32Bx8
id=b1slEAAAQBAJ&pg=RA2-PA121&img=1&zoom=3&hl=en&sig=ACfU3U0Ke-5
id=b1slEAAAQBAJ&pg=RA2-PA122&img=1&zoom=3&hl=en&sig=ACfU3U0zraB
id=b1slEAAAQBAJ&pg=RA2-PA123&img=1&zoom=3&hl=en&sig=ACfU3U1xKvX
id=b1slEAAAQBAJ&pg=RA2-PA124&img=1&zoom=3&hl=en&sig=ACfU3U2409I
id=b1slEAAAQBAJ&pg=RA2-PA125&img=1&zoom=3&hl=en&sig=ACfU3U2-Zsl
id=b1slEAAAQBAJ&pg=RA2-PA126&img=1&zoom=3&hl=en&sig=ACfU3U1ht3e
id=b1slEAAAQBAJ&pg=RA2-PA127&img=1&zoom=3&hl=en&sig=ACfU3U2RK-J
id=b1slEAAAQBAJ&pg=RA2-PA128&img=1&zoom=3&hl=en&sig=ACfU3U1G-7S
id=b1slEAAAQBAJ&pg=RA2-PA129&img=1&zoom=3&hl=en&sig=ACfU3U2SWJj
id=b1slEAAAQBAJ&pg=RA2-PA130&img=1&zoom=3&hl=en&sig=ACfU3U2JDld
id=b1slEAAAQBAJ&pg=RA2-PA131&img=1&zoom=3&hl=en&sig=ACfU3U1hjKP
id=b1slEAAAQBAJ&pg=RA2-PA132&img=1&zoom=3&hl=en&sig=ACfU3U0ty9L
id=b1slEAAAQBAJ&pg=RA2-PA133&img=1&zoom=3&hl=en&sig=ACfU3U3oM2F
id=b1slEAAAQBAJ&pg=RA2-PA134&img=1&zoom=3&hl=en&sig=ACfU3U1LD-C
id=b1slEAAAQBAJ&pg=RA2-PA135&img=1&zoom=3&hl=en&sig=ACfU3U36EMS
id=b1slEAAAQBAJ&pg=RA2-PA136&img=1&zoom=3&hl=en&sig=ACfU3U1AOCq
id=b1slEAAAQBAJ&pg=RA2-PA137&img=1&zoom=3&hl=en&sig=ACfU3U034KR
id=b1slEAAAQBAJ&pg=RA2-PA138&img=1&zoom=3&hl=en&sig=ACfU3U0fqEn
id=b1slEAAAQBAJ&pg=RA2-PA139&img=1&zoom=3&hl=en&sig=ACfU3U22VEd
id=b1slEAAAQBAJ&pg=RA2-PA140&img=1&zoom=3&hl=en&sig=ACfU3U2fisG
id=b1slEAAAQBAJ&pg=RA2-PA141&img=1&zoom=3&hl=en&sig=ACfU3U1atRL
id=b1slEAAAQBAJ&pg=RA2-PA142&img=1&zoom=3&hl=en&sig=ACfU3U1V55a
id=b1slEAAAQBAJ&pg=RA2-PA143&img=1&zoom=3&hl=en&sig=ACfU3U0JrXN
id=b1slEAAAQBAJ&pg=RA2-PA144&img=1&zoom=3&hl=en&sig=ACfU3U1sky7
id=b1slEAAAQBAJ&pg=RA2-PA145&img=1&zoom=3&hl=en&sig=ACfU3U0emIz
id=b1slEAAAQBAJ&pg=RA2-PA146&img=1&zoom=3&hl=en&sig=ACfU3U2WKcP
id=b1slEAAAQBAJ&pg=RA2-PA147&img=1&zoom=3&hl=en&sig=ACfU3U2O9AZ
id=b1slEAAAQBAJ&pg=RA2-PA148&img=1&zoom=3&hl=en&sig=ACfU3U30yOB
id=b1slEAAAQBAJ&pg=RA2-PA149&img=1&zoom=3&hl=en&sig=ACfU3U2GtZ8
id=b1slEAAAQBAJ&pg=RA2-PA150&img=1&zoom=3&hl=en&sig=ACfU3U2Pfhc
id=b1slEAAAQBAJ&pg=RA2-PA151&img=1&zoom=3&hl=en&sig=ACfU3U1_ncN
id=b1slEAAAQBAJ&pg=RA2-PA152&img=1&zoom=3&hl=en&sig=ACfU3U0AjxD
id=b1slEAAAQBAJ&pg=RA2-PA153&img=1&zoom=3&hl=en&sig=ACfU3U3zyQU
id=b1slEAAAQBAJ&pg=RA2-PA154&img=1&zoom=3&hl=en&sig=ACfU3U1De0b
id=b1slEAAAQBAJ&pg=RA2-PA155&img=1&zoom=3&hl=en&sig=ACfU3U3pCYd
id=b1slEAAAQBAJ&pg=RA2-PA156&img=1&zoom=3&hl=en&sig=ACfU3U0S8kN
id=b1slEAAAQBAJ&pg=RA2-PA157&img=1&zoom=3&hl=en&sig=ACfU3U1mANm
id=b1slEAAAQBAJ&pg=RA2-PA158&img=1&zoom=3&hl=en&sig=ACfU3U3xqDk
id=b1slEAAAQBAJ&pg=RA2-PA159&img=1&zoom=3&hl=en&sig=ACfU3U344ZP
id=b1slEAAAQBAJ&pg=RA2-PA160&img=1&zoom=3&hl=en&sig=ACfU3U0qVuF
id=b1slEAAAQBAJ&pg=RA2-PA161&img=1&zoom=3&hl=en&sig=ACfU3U3RMuQ
id=b1slEAAAQBAJ&pg=RA2-PA162&img=1&zoom=3&hl=en&sig=ACfU3U29cxf
id=b1slEAAAQBAJ&pg=RA2-PA163&img=1&zoom=3&hl=en&sig=ACfU3U2ZxtK
id=b1slEAAAQBAJ&pg=RA2-PA164&img=1&zoom=3&hl=en&sig=ACfU3U2frny
id=b1slEAAAQBAJ&pg=RA2-PA165&img=1&zoom=3&hl=en&sig=ACfU3U3BZ5C
id=b1slEAAAQBAJ&pg=RA2-PA166&img=1&zoom=3&hl=en&sig=ACfU3U0iv3P
id=b1slEAAAQBAJ&pg=RA2-PA167&img=1&zoom=3&hl=en&sig=ACfU3U0gXYT
id=b1slEAAAQBAJ&pg=RA2-PA168&img=1&zoom=3&hl=en&sig=ACfU3U1WnIy
id=b1slEAAAQBAJ&pg=RA2-PA169&img=1&zoom=3&hl=en&sig=ACfU3U3foQH
id=b1slEAAAQBAJ&pg=RA2-PA170&img=1&zoom=3&hl=en&sig=ACfU3U0IJzr
id=b1slEAAAQBAJ&pg=RA2-PA171&img=1&zoom=3&hl=en&sig=ACfU3U2pEDa
id=b1slEAAAQBAJ&pg=RA2-PA172&img=1&zoom=3&hl=en&sig=ACfU3U0FGiU
id=b1slEAAAQBAJ&pg=RA2-PA173&img=1&zoom=3&hl=en&sig=ACfU3U38JHR
id=b1slEAAAQBAJ&pg=RA2-PA174&img=1&zoom=3&hl=en&sig=ACfU3U0bVs2
id=b1slEAAAQBAJ&pg=RA2-PA175&img=1&zoom=3&hl=en&sig=ACfU3U3X9Y5
id=b1slEAAAQBAJ&pg=RA2-PA176&img=1&zoom=3&hl=en&sig=ACfU3U2n-k4
id=b1slEAAAQBAJ&pg=RA2-PA177&img=1&zoom=3&hl=en&sig=ACfU3U2KzXY
index Z
id=b1slEAAAQBAJ&pg=RA2-PA178&img=1&zoom=3&hl=en&sig=ACfU3U0kTNh
id=b1slEAAAQBAJ&pg=RA2-PA179&img=1&zoom=3&hl=en&sig=ACfU3U1ktJ2
id=b1slEAAAQBAJ&pg=RA2-PA180&img=1&zoom=3&hl=en&sig=ACfU3U2b8-T
id=b1slEAAAQBAJ&pg=RA2-PA181&img=1&zoom=3&hl=en&sig=ACfU3U1JR3r
id=b1slEAAAQBAJ&pg=RA2-PA182&img=1&zoom=3&hl=en&sig=ACfU3U2UV4X
id=b1slEAAAQBAJ&pg=RA2-PA183&img=1&zoom=3&hl=en&sig=ACfU3U1XhgM
id=b1slEAAAQBAJ&pg=RA2-PA184&img=1&zoom=3&hl=en&sig=ACfU3U1ytZu
id=b1slEAAAQBAJ&pg=RA2-PA185&img=1&zoom=3&hl=en&sig=ACfU3U29Pch
id=b1slEAAAQBAJ&pg=RA2-PA186&img=1&zoom=3&hl=en&sig=ACfU3U2-fjD
id=b1slEAAAQBAJ&pg=RA2-PA187&img=1&zoom=3&hl=en&sig=ACfU3U0xIPG
id=b1slEAAAQBAJ&pg=RA2-PA188&img=1&zoom=3&hl=en&sig=ACfU3U3Z3i5
id=b1slEAAAQBAJ&pg=RA2-PA189&img=1&zoom=3&hl=en&sig=ACfU3U0nexh
id=b1slEAAAQBAJ&pg=RA2-PA190&img=1&zoom=3&hl=en&sig=ACfU3U1sB7w
id=b1slEAAAQBAJ&pg=RA2-PA191&img=1&zoom=3&hl=en&sig=ACfU3U2J1fe
id=b1slEAAAQBAJ&pg=RA2-PA192&img=1&zoom=3&hl=en&sig=ACfU3U0mWUl
id=b1slEAAAQBAJ&pg=RA2-PA193&img=1&zoom=3&hl=en&sig=ACfU3U2kf9P
id=b1slEAAAQBAJ&pg=RA2-PA194&img=1&zoom=3&hl=en&sig=ACfU3U3DB50
id=b1slEAAAQBAJ&pg=RA2-PA195&img=1&zoom=3&hl=en&sig=ACfU3U1gArM
id=b1slEAAAQBAJ&pg=RA2-PA196&img=1&zoom=3&hl=en&sig=ACfU3U38-L-
id=b1slEAAAQBAJ&pg=RA2-PA197&img=1&zoom=3&hl=en&sig=ACfU3U2BptM
id=b1slEAAAQBAJ&pg=RA2-PA198&img=1&zoom=3&hl=en&sig=ACfU3U1lqNz
id=b1slEAAAQBAJ&pg=RA2-PA199&img=1&zoom=3&hl=en&sig=ACfU3U24RGT
id=b1slEAAAQBAJ&pg=RA2-PA200&img=1&zoom=3&hl=en&sig=ACfU3U0bVPN
id=b1slEAAAQBAJ&pg=RA2-PA201&img=1&zoom=3&hl=en&sig=ACfU3U3720K
id=b1slEAAAQBAJ&pg=RA2-PA202&img=1&zoom=3&hl=en&sig=ACfU3U3qokz
id=b1slEAAAQBAJ&pg=RA2-PA203&img=1&zoom=3&hl=en&sig=ACfU3U3M4Gb
id=b1slEAAAQBAJ&pg=RA2-PA204&img=1&zoom=3&hl=en&sig=ACfU3U0-VWE
id=b1slEAAAQBAJ&pg=RA2-PA205&img=1&zoom=3&hl=en&sig=ACfU3U2wZM7
id=b1slEAAAQBAJ&pg=RA2-PA206&img=1&zoom=3&hl=en&sig=ACfU3U0u569
id=b1slEAAAQBAJ&pg=RA2-PA207&img=1&zoom=3&hl=en&sig=ACfU3U0eclh
id=b1slEAAAQBAJ&pg=RA2-PA208&img=1&zoom=3&hl=en&sig=ACfU3U2fAzn
id=b1slEAAAQBAJ&pg=RA2-PA209&img=1&zoom=3&hl=en&sig=ACfU3U1bUnn
id=b1slEAAAQBAJ&pg=RA2-PA210&img=1&zoom=3&hl=en&sig=ACfU3U3Cvtp
id=b1slEAAAQBAJ&pg=RA2-PA211&img=1&zoom=3&hl=en&sig=ACfU3U0ANVz
id=b1slEAAAQBAJ&pg=RA2-PA212&img=1&zoom=3&hl=en&sig=ACfU3U3IatD
id=b1slEAAAQBAJ&pg=RA2-PA213&img=1&zoom=3&hl=en&sig=ACfU3U14UpL
id=b1slEAAAQBAJ&pg=RA2-PA214&img=1&zoom=3&hl=en&sig=ACfU3U3mlgc
id=b1slEAAAQBAJ&pg=RA2-PA215&img=1&zoom=3&hl=en&sig=ACfU3U0fN_h
id=b1slEAAAQBAJ&pg=RA2-PA216&img=1&zoom=3&hl=en&sig=ACfU3U3R5Mt
id=b1slEAAAQBAJ&pg=RA2-PA217&img=1&zoom=3&hl=en&sig=ACfU3U052Pp
id=b1slEAAAQBAJ&pg=RA2-PA218&img=1&zoom=3&hl=en&sig=ACfU3U2H072
id=b1slEAAAQBAJ&pg=RA2-PA219&img=1&zoom=3&hl=en&sig=ACfU3U3MNPN
id=b1slEAAAQBAJ&pg=RA2-PA220&img=1&zoom=3&hl=en&sig=ACfU3U1r3Sl
id=b1slEAAAQBAJ&pg=RA2-PA221&img=1&zoom=3&hl=en&sig=ACfU3U342dU
id=b1slEAAAQBAJ&pg=RA2-PA222&img=1&zoom=3&hl=en&sig=ACfU3U25yqS
id=b1slEAAAQBAJ&pg=RA2-PA223&img=1&zoom=3&hl=en&sig=ACfU3U0kFBL
id=b1slEAAAQBAJ&pg=RA2-PA224&img=1&zoom=3&hl=en&sig=ACfU3U3qo9g
id=b1slEAAAQBAJ&pg=RA2-PA225&img=1&zoom=3&hl=en&sig=ACfU3U3kSHl
id=b1slEAAAQBAJ&pg=RA2-PA226&img=1&zoom=3&hl=en&sig=ACfU3U14XJ_
id=b1slEAAAQBAJ&pg=RA2-PA227&img=1&zoom=3&hl=en&sig=ACfU3U182Jn
id=b1slEAAAQBAJ&pg=RA2-PA228&img=1&zoom=3&hl=en&sig=ACfU3U1QgTI
id=b1slEAAAQBAJ&pg=RA2-PA229&img=1&zoom=3&hl=en&sig=ACfU3U3KyF9
blank.pdf (p.2876)
04
